StockData

Zhengye Biotechnology Holding Ltd (ZYBT) stock

ZYBTNasdaqPharmaceutical Preparations
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 28, 2026Score 4/30
$1.50−0.02 (-1.32%)

Close on Nov 18, 2026Market cap $71.09MP/E –Yield –

Zhengye Biotechnology operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2025 it was CN¥13.33M, down 67.5% from the year before.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025CN¥13.33M-67.5%
FY2024Dec 31, 2024CN¥41.05M-14.8%
FY2023Dec 31, 2023CN¥48.18M+178.0%
FY2022Dec 31, 2022CN¥17.34M–

More Zhengye Biotechnology figures

See a number that looks wrong?